First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient

EJHaem. 2020 Dec 8;2(1):143-146. doi: 10.1002/jha2.132. eCollection 2021 Feb.

Authors

Nicholas Fordham^{1

2}, Emma Baker³, Daniel Forton⁴, Matthias Klammer¹, Kamal Patel⁴, Dara Qadir¹, Yasmin Reyal¹, Fenella Willis¹, Mickey B C Koh^{1

5}

Affiliations

¹ Haematology Department St George's University Hospitals NHS Foundation Trust London UK.
² St Catherine's College University of Oxford Oxford UK.
³ Institute of Infection and Immunity St George's University of London UK.
⁴ Department of Gastroenterology and Hepatology St George's University Hospitals NHS Foundation Trust London UK.
⁵ Cell Therapy Programme Health Sciences Authority Singapore.

No abstract available